AN2 Therapeutics Inc. (ANTX) NASDAQ
$2.38 (0.10) (-4.03%)
Market Cap: $70.85M
As of 04/18/24 04:00 PM EDT. Market closed.
AN2 Therapeutics Inc. (ANTX)
NASDAQ
$2.38
(0.10) (-4.03%)
Market Cap: $70.85M
As of 04/18/24 04:00 PM EDT. Market closed.
Add to Portfolio
an2 therapeutics, inc. is a california-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. an2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for ... read more
an2 therapeutics, inc. is a california-based global health biopharmaceutical company focused on bringing the power of modern biomedical and drug development expertise to provide transformational medicines for patients suffering from infectious diseases. an2 is a mission-driven company, with a vision for humanity to be free from the threat of infectious diseases by addressing the urgent need for new treatments that can save lives across the globe. founded by a small team of biopharmaceutical industry leaders with a passion for global health and experience in infectious disease drug r&d, we strive to bring patients treatments that will restore their health and enable them to live productive lives. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
Sector
Manufacturing
Industry
Medicinal and Botanical Manufacturing
URL
Address
.
PRICE CHART FOR AN2 THERAPEUTICS INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$2.43
Previous Close
$2.48
Days Range
$2.37 - $2.51
52 week range
$2.36 - $22.22
Volume
145,364
Avg. Volume (30 days)
396,290
Market Cap
$70.85M
Dividend Yield
-
P/E
-
Shares Outstanding
29,770,375
Open
$2.43
Previous Close
$2.48
Days Range
$2.37 - $2.51
52 week range
$2.36 - $22.22
Volume
145,364
Avg. Volume (30 days)
396,290
Market Cap
$70.85M
Dividend Yield
-
P/E
-
Shares Outstanding
29,770,375
FINANCIAL STATEMENTS FOR AN2 THERAPEUTICS INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR AN2 THERAPEUTICS INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Zakrzewski Joseph S | Director | Jan 18, 2024 | Sale | $19.11 | 100,000 | 1,911,410 | 405,880 | Jan 19, 2024, 07:32 PM |
| Aziz Kabeer | Director | Jan 16, 2024 | Sale | $19.65 | 15,907 | 312,573 | 377,542 | Jan 18, 2024, 06:19 PM |
| Aziz Kabeer | Director | Jan 16, 2024 | Sale | $19.65 | 84,093 | 1,652,427 | 1,995,958 | Jan 18, 2024, 06:19 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Jan 16, 2024 | Sale | $19.65 | 15,907 | 312,573 | 377,542 | Jan 18, 2024, 06:18 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Jan 16, 2024 | Sale | $19.65 | 84,093 | 1,652,427 | 1,995,958 | Jan 18, 2024, 06:18 PM |
| Readnour Robin Shane | Director | Jan 12, 2024 | Sale | $21.91 | 1,425 | 31,229 | 485,073 | Jan 17, 2024, 05:03 PM |
| Readnour Robin Shane | Director | Jan 10, 2024 | Sale | $21.93 | 3,669 | 80,443 | 485,792 | Jan 12, 2024, 05:08 PM |
| Krause Kevin Michael | Chief Strategy Officer | Jan 09, 2024 | Option Exercise | $4.59 | 7,417 | 34,015 | 9,331 | Jan 11, 2024, 07:59 PM |
| Krause Kevin Michael | Chief Strategy Officer | Jan 09, 2024 | Sale | $20.14 | 7,417 | 149,367 | 1,914 | Jan 11, 2024, 07:59 PM |
| Krause Kevin Michael | Chief Strategy Officer | Jan 02, 2024 | Option Exercise | $0.42 | 2,583 | 1,085 | 4,497 | Jan 04, 2024, 06:06 PM |
| Krause Kevin Michael | Chief Strategy Officer | Jan 02, 2024 | Sale | $20.12 | 2,583 | 51,967 | 1,914 | Jan 04, 2024, 06:06 PM |
| Easom Eric | Chief Executive Officer | Jan 02, 2024 | Sale | $20.09 | 2,777 | 55,802 | 2,130 | Jan 04, 2024, 06:05 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Nov 14, 2023 | Sale | $16.15 | 288 | 4,650 | 393,449 | Nov 16, 2023, 06:59 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Nov 14, 2023 | Sale | $16.15 | 1,522 | 24,574 | 2,080,051 | Nov 16, 2023, 06:59 PM |
| Aziz Kabeer | Director | Nov 14, 2023 | Sale | $16.15 | 288 | 4,650 | 393,449 | Nov 16, 2023, 06:57 PM |
| Aziz Kabeer | Director | Nov 14, 2023 | Sale | $16.15 | 1,522 | 24,574 | 2,080,051 | Nov 16, 2023, 06:57 PM |
| Aziz Kabeer | Director | Sep 29, 2023 | Sale | $16.28 | 15,764 | 256,638 | 394,639 | Oct 03, 2023, 07:21 PM |
| Aziz Kabeer | Director | Sep 29, 2023 | Sale | $16.28 | 83,337 | 1,356,726 | 2,086,343 | Oct 03, 2023, 07:21 PM |
| Aziz Kabeer | Director | Oct 02, 2023 | Sale | $16.07 | 902 | 14,495 | 393,737 | Oct 03, 2023, 07:21 PM |
| Aziz Kabeer | Director | Oct 02, 2023 | Sale | $16.07 | 4,770 | 76,654 | 2,081,573 | Oct 03, 2023, 07:21 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Oct 02, 2023 | Sale | $16.07 | 902 | 14,495 | 393,737 | Oct 03, 2023, 07:13 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Oct 02, 2023 | Sale | $16.07 | 4,770 | 76,654 | 2,081,573 | Oct 03, 2023, 07:13 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 29, 2023 | Sale | $16.28 | 15,764 | 256,638 | 394,639 | Oct 03, 2023, 07:13 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 29, 2023 | Sale | $16.28 | 83,337 | 1,356,726 | 2,086,343 | Oct 03, 2023, 07:13 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 27, 2023 | Sale | $16.07 | 707 | 11,361 | 2,176,840 | Sep 29, 2023, 05:41 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 28, 2023 | Sale | $16.11 | 1,356 | 21,845 | 410,403 | Sep 29, 2023, 05:41 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 28, 2023 | Sale | $16.11 | 7,160 | 115,348 | 2,169,680 | Sep 29, 2023, 05:41 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 27, 2023 | Sale | $16.07 | 134 | 2,153 | 411,759 | Sep 29, 2023, 05:41 PM |
| Aziz Kabeer | Director | Sep 28, 2023 | Sale | $16.11 | 7,160 | 115,348 | 2,169,680 | Sep 29, 2023, 05:40 PM |
| Aziz Kabeer | Director | Sep 27, 2023 | Sale | $16.07 | 134 | 2,153 | 411,759 | Sep 29, 2023, 05:40 PM |
| Aziz Kabeer | Director | Sep 27, 2023 | Sale | $16.07 | 707 | 11,361 | 2,176,840 | Sep 29, 2023, 05:40 PM |
| Aziz Kabeer | Director | Sep 28, 2023 | Sale | $16.11 | 1,356 | 21,845 | 410,403 | Sep 29, 2023, 05:40 PM |
| Aziz Kabeer | Director | Sep 13, 2023 | Sale | $16.00 | 64 | 1,024 | 411,893 | Sep 15, 2023, 05:40 PM |
| Aziz Kabeer | Director | Sep 13, 2023 | Sale | $16.00 | 336 | 5,376 | 2,177,547 | Sep 15, 2023, 05:40 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 13, 2023 | Sale | $16.00 | 64 | 1,024 | 411,893 | Sep 15, 2023, 05:17 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 13, 2023 | Sale | $16.00 | 336 | 5,376 | 2,177,547 | Sep 15, 2023, 05:17 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 07, 2023 | Sale | $16.05 | 537 | 8,619 | 411,957 | Sep 08, 2023, 04:59 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 07, 2023 | Sale | $16.05 | 2,841 | 45,598 | 2,177,883 | Sep 08, 2023, 04:59 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 06, 2023 | Sale | $16.02 | 598 | 9,580 | 412,494 | Sep 08, 2023, 04:59 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Sep 06, 2023 | Sale | $16.02 | 3,164 | 50,687 | 2,180,724 | Sep 08, 2023, 04:59 PM |
| Aziz Kabeer | Director | Sep 06, 2023 | Sale | $16.02 | 598 | 9,580 | 412,494 | Sep 08, 2023, 04:57 PM |
| Aziz Kabeer | Director | Sep 06, 2023 | Sale | $16.02 | 3,164 | 50,687 | 2,180,724 | Sep 08, 2023, 04:57 PM |
| Aziz Kabeer | Director | Sep 07, 2023 | Sale | $16.05 | 537 | 8,619 | 411,957 | Sep 08, 2023, 04:57 PM |
| Aziz Kabeer | Director | Sep 07, 2023 | Sale | $16.05 | 2,841 | 45,598 | 2,177,883 | Sep 08, 2023, 04:57 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Aug 23, 2023 | Sale | $16.00 | 64 | 1,024 | 413,092 | Aug 25, 2023, 04:31 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Aug 23, 2023 | Sale | $16.00 | 336 | 5,376 | 2,183,888 | Aug 25, 2023, 04:31 PM |
| Aziz Kabeer | Director | Aug 23, 2023 | Sale | $16.00 | 64 | 1,024 | 413,092 | Aug 25, 2023, 04:30 PM |
| Aziz Kabeer | Director | Aug 23, 2023 | Sale | $16.00 | 336 | 5,376 | 2,183,888 | Aug 25, 2023, 04:30 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Aug 18, 2023 | Buy | $9.00 | 1,777,778 | 16,000,002 | 5,135,683 | Aug 22, 2023, 05:01 PM |
| Easom Eric | Chief Executive Officer | May 15, 2023 | Buy | $5.38 | 10,000 | 53,770 | 1,015,766 | May 15, 2023, 08:01 PM |
| Easom Eric | Chief Executive Officer | Nov 14, 2022 | Sale | $15.04 | 23 | 346 | 4,907 | Nov 14, 2022, 08:48 PM |
| Easom Eric | Chief Executive Officer | Nov 10, 2022 | Sale | $15.32 | 4,413 | 67,628 | 4,930 | Nov 14, 2022, 08:48 PM |
| Easom Eric | Chief Executive Officer | Nov 09, 2022 | Sale | $15.61 | 10,111 | 157,847 | 4,907 | Nov 09, 2022, 08:33 PM |
| Easom Eric | Chief Executive Officer | Nov 08, 2022 | Sale | $15.58 | 7,055 | 109,947 | 16,273 | Nov 09, 2022, 08:33 PM |
| Easom Eric | Chief Executive Officer | Nov 07, 2022 | Sale | $16.04 | 12,203 | 195,741 | 6,943 | Nov 07, 2022, 08:19 PM |
| Easom Eric | Chief Executive Officer | Nov 04, 2022 | Sale | $15.80 | 8,828 | 139,474 | 17,110 | Nov 07, 2022, 08:19 PM |
| Easom Eric | Chief Executive Officer | Nov 03, 2022 | Sale | $15.75 | 14,165 | 223,058 | 29,021 | Nov 07, 2022, 08:19 PM |
| Easom Eric | Chief Executive Officer | Nov 02, 2022 | Sale | $15.07 | 1,544 | 23,263 | 4,907 | Nov 02, 2022, 08:52 PM |
| Easom Eric | Chief Executive Officer | Oct 31, 2022 | Sale | $15.39 | 2,688 | 41,363 | 6,451 | Nov 02, 2022, 08:52 PM |
| Easom Eric | Chief Executive Officer | Oct 28, 2022 | Sale | $15.09 | 1,683 | 25,392 | 4,907 | Oct 28, 2022, 08:27 PM |
| Easom Eric | Chief Executive Officer | Oct 27, 2022 | Sale | $15.36 | 924 | 14,190 | 6,590 | Oct 28, 2022, 08:27 PM |
| Easom Eric | Chief Executive Officer | Oct 24, 2022 | Sale | $16.17 | 2,866 | 46,344 | 11,391 | Oct 26, 2022, 09:19 PM |
| Easom Eric | Chief Executive Officer | Oct 26, 2022 | Sale | $15.10 | 1,678 | 25,342 | 4,907 | Oct 26, 2022, 09:19 PM |
| Easom Eric | Chief Executive Officer | Oct 25, 2022 | Sale | $15.75 | 4,806 | 75,672 | 7,119 | Oct 26, 2022, 09:19 PM |
| Easom Eric | Chief Executive Officer | Oct 21, 2022 | Sale | $16.36 | 13,951 | 228,240 | 7,257 | Oct 24, 2022, 09:44 PM |
| Easom Eric | Chief Executive Officer | Oct 20, 2022 | Sale | $16.68 | 7,293 | 121,672 | 18,889 | Oct 24, 2022, 09:44 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Aug 04, 2022 | Buy | $7.99 | 100 | 799 | 3,773,517 | Aug 05, 2022, 04:06 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Aug 03, 2022 | Buy | $7.48 | 1,809 | 13,531 | 3,773,417 | Aug 05, 2022, 04:06 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jul 27, 2022 | Buy | $7.91 | 8,281 | 65,503 | 3,771,608 | Jul 28, 2022, 05:16 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jul 26, 2022 | Buy | $7.71 | 14,938 | 115,172 | 3,763,327 | Jul 28, 2022, 05:16 PM |
| Aziz Kabeer | Director | Jun 06, 2022 | Option Exercise | $15.00 | 26,511 | 397,665 | 413,156 | Jun 24, 2022, 05:10 PM |
| Aziz Kabeer | Director | Jun 06, 2022 | Option Exercise | $15.00 | 26,511 | 397,665 | 2,184,224 | Jun 24, 2022, 05:10 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Jun 06, 2022 | Option Exercise | $15.00 | 26,511 | 397,665 | 413,156 | Jun 24, 2022, 05:06 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Jun 06, 2022 | Option Exercise | $15.00 | 26,511 | 397,665 | 2,184,224 | Jun 24, 2022, 05:06 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Mar 29, 2022 | Buy | $15.00 | 166,666 | 2,499,990 | 2,210,735 | Jun 24, 2022, 04:51 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 21, 2022 | Buy | $7.99 | 302 | 2,413 | 3,748,389 | Jun 23, 2022, 04:31 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 14, 2022 | Buy | $7.97 | 61,424 | 489,402 | 3,748,087 | Jun 15, 2022, 04:25 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Jun 13, 2022 | Buy | $7.90 | 20,000 | 158,000 | 3,686,663 | Jun 15, 2022, 04:25 PM |
| Readnour Robin Shane | Director | Mar 29, 2022 | Buy | $15.00 | 153,334 | 2,300,010 | 487,592 | Mar 31, 2022, 08:15 PM |
| Adjuvant Global Health Technology Fund, L.P. | 10% Owner | Mar 29, 2022 | Buy | $15.00 | 166,666 | 2,499,990 | 2,210,735 | Mar 31, 2022, 08:15 PM |
| Aziz Kabeer | Director | Mar 29, 2022 | Buy | $15.00 | 166,666 | 2,499,990 | 2,210,735 | Mar 31, 2022, 08:15 PM |
| RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Mar 29, 2022 | Buy | $15.00 | 1,666,666 | 24,999,990 | 3,251,051 | Mar 31, 2022, 04:31 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN AN2 THERAPEUTICS INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 5,551,295 | 1.78% | No change | Other |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 900,672 | 0.04% | -0.54% | Other |
| BLACKROCK INC. | 305,841 | 0.00016% | 625.39% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 178,623 | 0.00038% | 99.15% | Other |
| BALYASNY ASSET MANAGEMENT L.P. | 19,285 | 0.00074% | New | Event Driven |
CHANGE IN SHARES OUTSTANDING FOR AN2 THERAPEUTICS INC
STOCK BUYBACKS FOR AN2 THERAPEUTICS INC
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
-7.98%
1Q
06/30/2023
21.04%
2Q
03/31/2023
21.74%
3Q
09/30/2022
21.98%
5Q
06/30/2022
22.55%
6Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR AN2 THERAPEUTICS INC
LOADING...